Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; CAREWare Customer Satisfaction and Usage Survey, OMB No. 0906-xxxx-New, 2228-2229 [2024-00534]
Download as PDF
2228
Federal Register / Vol. 89, No. 9 / Friday, January 12, 2024 / Notices
INCLUSION AND EXCLUSION CRITERIA BY POPULATION, INTERVENTION, COMPARATOR, OUTCOME, TIMING, SETTING/STUDY
DESIGN (PICOTS)—Continued
PICOTS elements
Timing ..................................
Settings ................................
Study design ........................
Inclusion criteria
•
•
•
•
•
•
•
Publications ..........................
•
•
•
Exclusion criteria
At least 4 weeks ..........................................................
All except hospital and acute care ..............................
Randomized controlled trials .......................................
Nonrandomized controlled trials, including quasi-experimental and controlled before-and-after studies.
Prospective cohort studies.
Nested case-control studies.
Relevant systematic reviews, or meta-analyses (used
for identifying additional studies).
Studies published in English only ...............................
Studies published in peer-reviewed journals.
Studies published at and after the year 2000.
• Less than 4 weeks.
• Hospital and acute care.
• In vitro studies, nonoriginal data (e.g., narrative reviews, scoping reviews, editorials, letters, or erratum), retrospective cohort studies, case series, qualitative studies, cost-benefit analysis, cross-sectional
(i.e., nonlongitudinal) studies, survey.
• Non-English language studies.
Abbreviations: CVD = cardiovascular disease; GI = gastrointestinal; HDL = high-density lipoprotein; KQ = Key Question; LDL = low-density
lipoprotein PICOTS = populations, interventions, comparators, outcomes, timing, and settings; RCT = randomized controlled trial; TC = total cholesterol; U.S. = United States.
Dated: January 8, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024–00505 Filed 1–11–24; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; CAREWare Customer
Satisfaction and Usage Survey, OMB
No. 0906–xxxx–New
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period. OMB may act on
HRSA’s ICR only after the 30-day
comment period for this notice has
closed.
DATES: Comments on this ICR should be
received no later than February 12,
2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
00:38 Jan 12, 2024
Jkt 262001
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email
Joella Roland, the HRSA Information
Collection Clearance Officer at
paperwork@hrsa.gov or call (301) 443–
3983.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
CAREWare Customer Satisfaction and
Usage Survey, OMB No. 0906–xxxx–
New.
Abstract: HRSA developed
CAREWare, a software application first
released in 2000, to help meet the data
collection and reporting needs of Ryan
White HIV/AIDS Program (RWHAP)
grant recipients. The secure software is
a free, electronic health and social
support services information system for
RWHAP grant recipients and their
subrecipients to assist in the data
requirement submissions that inform
the development of the Ryan White
HIV/AIDS Program Service Report, the
AIDS Drug Assistance Program Data
Report, the Ending the HIV Epidemic
Initiative Triannual Report, and the
voluntary Clinical Quality Measures
Performance Measures module. Over
time, the software has evolved into a
comprehensive health information
system and is now the source of more
than half of all the RWHAP client-level
data received from recipients and
subrecipients of RWHAP grant funding.
CAREWare software manages HIV
clinical and support service data from
more than 360,000 client records in 48
states; Washington, DC; Puerto Rico;
and the U.S. Virgin Islands.
The CAREWare software application
contains customizable modules for
tracking demographic information,
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
services, medications, laboratory test
results, immunization history, diagnoses
(updated with International
Classification of Diseases, Tenth
Revision codes), referrals to outside
agencies, and an appointment
scheduler. There is a custom report
generator and a performance measures
module that supports quality of care
initiatives at the provider level. The
software also has several ways to import
data from third-party sources, including
commercial labs and other electronic
health records (using both Health Level
Seven and simple Comma Separated
Value-formatted files), HIV surveillance
systems, and for RWHAP Part B AIDS
Drug Assistance Programs, pharmacy
benefit programs. The software and user
support materials can be accessed here:
https://hab.hrsa.gov/program-grantsmanagement/careware. Finally,
CAREWare supports users through an
experienced helpdesk with ongoing
software maintenance issues and
enhancements to the user interface.
HRSA is proposing a customer
satisfaction survey to gather feedback
from CAREWare users regarding their
experiences and satisfaction with the
software platform and to obtain
suggestions for improvement.
A 60-day Federal Register Notice
(FRN) was published in the Federal
Register on October 20, 2023 (Volume
88, No. 202, pages 72493–94). There was
one out-of-scope public comment
received in response to the FRN.
Need and Proposed Use of the
Information: HRSA aims to understand
CAREWare users’ needs and concerns
by collecting information on current
software features and inquiring about
opportunities to improve the user
experience and product features. The
survey will address the software’s
functionality and how well it meets the
data collection, reporting, and quality
E:\FR\FM\12JAN1.SGM
12JAN1
2229
Federal Register / Vol. 89, No. 9 / Friday, January 12, 2024 / Notices
management needs of the CAREWare
user. The feedback will enable HRSA to
assess, benchmark, and improve
customer satisfaction with RWHAP
grant recipients.
Likely Respondents: RWHAP
recipients and providers who use
CAREWare to produce data files for the
Ryan White HIV/AIDS Program Service
Report, the AIDS Drug Assistance
Program Data Report, the Ending the
HIV Epidemic Initiative Triannual
Report, and the voluntary Clinical
Quality Measures Performance
Measures module.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
A pilot with seven RWHAP grant
recipients concluded on November 20,
2023, one month after the 60-day FRN
publication date of October 20, 2023.
The pilot resulted in a lesser burden
estimate than initially reported in the
60-day FRN.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
CAREWare User Survey .....................................................
1,160
1
1,160
0.88
1,021
Total ..............................................................................
1,160
1
1,160
0.88
1,021
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–00534 Filed 1–11–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
VerDate Sep<11>2014
00:38 Jan 12, 2024
Jkt 262001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Small Business Innovation
Research (SBIR) Phase II Program Contract
Solicitation (PHS 2022–1) Topic 109—
Development of Monoclonal Antibodymediated Interventions to Combat Malaria
(N01).
Date: February 6, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F36,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Noton K. Dutta, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F36, Rockville, MD
20852, 240–669–2857, noton.dutta@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 9, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00556 Filed 1–11–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2024–1 Phase I: Alternatives to Benzathine
Penicillin for Treatment of Syphilis (Topic
134).
Date: February 12, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F52A
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Shilpakala Ketha, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
E:\FR\FM\12JAN1.SGM
12JAN1
Agencies
[Federal Register Volume 89, Number 9 (Friday, January 12, 2024)]
[Notices]
[Pages 2228-2229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00534]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request; CAREWare Customer
Satisfaction and Usage Survey, OMB No. 0906-xxxx-New
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with of the Paperwork Reduction Act of 1995,
HRSA has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period. OMB may act on HRSA's ICR only after the
30-day comment period for this notice has closed.
DATES: Comments on this ICR should be received no later than February
12, 2024.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email Joella Roland, the HRSA
Information Collection Clearance Officer at [email protected] or call
(301) 443-3983.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: CAREWare Customer
Satisfaction and Usage Survey, OMB No. 0906-xxxx-New.
Abstract: HRSA developed CAREWare, a software application first
released in 2000, to help meet the data collection and reporting needs
of Ryan White HIV/AIDS Program (RWHAP) grant recipients. The secure
software is a free, electronic health and social support services
information system for RWHAP grant recipients and their subrecipients
to assist in the data requirement submissions that inform the
development of the Ryan White HIV/AIDS Program Service Report, the AIDS
Drug Assistance Program Data Report, the Ending the HIV Epidemic
Initiative Triannual Report, and the voluntary Clinical Quality
Measures Performance Measures module. Over time, the software has
evolved into a comprehensive health information system and is now the
source of more than half of all the RWHAP client-level data received
from recipients and subrecipients of RWHAP grant funding. CAREWare
software manages HIV clinical and support service data from more than
360,000 client records in 48 states; Washington, DC; Puerto Rico; and
the U.S. Virgin Islands.
The CAREWare software application contains customizable modules for
tracking demographic information, services, medications, laboratory
test results, immunization history, diagnoses (updated with
International Classification of Diseases, Tenth Revision codes),
referrals to outside agencies, and an appointment scheduler. There is a
custom report generator and a performance measures module that supports
quality of care initiatives at the provider level. The software also
has several ways to import data from third-party sources, including
commercial labs and other electronic health records (using both Health
Level Seven and simple Comma Separated Value-formatted files), HIV
surveillance systems, and for RWHAP Part B AIDS Drug Assistance
Programs, pharmacy benefit programs. The software and user support
materials can be accessed here: https://hab.hrsa.gov/program-grants-management/careware. Finally, CAREWare supports users through an
experienced helpdesk with ongoing software maintenance issues and
enhancements to the user interface.
HRSA is proposing a customer satisfaction survey to gather feedback
from CAREWare users regarding their experiences and satisfaction with
the software platform and to obtain suggestions for improvement.
A 60-day Federal Register Notice (FRN) was published in the Federal
Register on October 20, 2023 (Volume 88, No. 202, pages 72493-94).
There was one out-of-scope public comment received in response to the
FRN.
Need and Proposed Use of the Information: HRSA aims to understand
CAREWare users' needs and concerns by collecting information on current
software features and inquiring about opportunities to improve the user
experience and product features. The survey will address the software's
functionality and how well it meets the data collection, reporting, and
quality
[[Page 2229]]
management needs of the CAREWare user. The feedback will enable HRSA to
assess, benchmark, and improve customer satisfaction with RWHAP grant
recipients.
Likely Respondents: RWHAP recipients and providers who use CAREWare
to produce data files for the Ryan White HIV/AIDS Program Service
Report, the AIDS Drug Assistance Program Data Report, the Ending the
HIV Epidemic Initiative Triannual Report, and the voluntary Clinical
Quality Measures Performance Measures module.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating, and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
A pilot with seven RWHAP grant recipients concluded on November 20,
2023, one month after the 60-day FRN publication date of October 20,
2023. The pilot resulted in a lesser burden estimate than initially
reported in the 60-day FRN.
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
CAREWare User Survey............ 1,160 1 1,160 0.88 1,021
-------------------------------------------------------------------------------
Total....................... 1,160 1 1,160 0.88 1,021
----------------------------------------------------------------------------------------------------------------
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-00534 Filed 1-11-24; 8:45 am]
BILLING CODE 4165-15-P